GABAPENTIN
NDC 76420-020, GABAPENTIN, capsule, from Asclemed USA, Inc..
- Product NDC
- 76420-020
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090705
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-020-24 | 76420002024 | 240 CAPSULE in 1 BOTTLE (76420-020-24) |
| 76420-020-30 | 76420002030 | 30 CAPSULE in 1 BOTTLE (76420-020-30) |
| 76420-020-60 | 76420002060 | 60 CAPSULE in 1 BOTTLE (76420-020-60) |
| 76420-020-90 | 76420002090 | 90 CAPSULE in 1 BOTTLE (76420-020-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/45039bba-7a96-450c-95be-83a3aa4fcbd2
Use it
Look up 76420-020 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-020 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-020. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.